Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases …

NE Kemeny, WR Jarnagin, M Capanu… - Journal of Clinical …, 2011 - ascopubs.org
Purpose Add systemic bevacizumab (Bev) to adjuvant hepatic arterial infusion (HAI) plus
systemic therapy after liver resection to increase recurrence-free survival (RFS). Patients …
被引用次数：134 相关文章

Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases …

NE Kemeny, WR Jarnagin… - Journal of clinical …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose Add systemic bevacizumab (Bev) to adjuvant hepatic arterial infusion (HAI) plus
systemic therapy after liver resection to increase recurrence-free survival (RFS). Patients …
[HTML] nih.gov

[HTML][HTML] Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic …

NE Kemeny, WR Jarnagin, M Capanu… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic
Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases …

[引用][C] Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic …

NE KEMENY, WR JARNAGIN… - Journal of clinical …, 2011 - pascal-francis.inist.fr
Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic
Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases …

Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases …

NE Kemeny, WR Jarnagin, M Capanu… - Journal of Clinical …, 2010 - europepmc.org
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with
or without bevacizumab in patients with resected hepatic metastases from colorectal cancer …

A randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases …

NE Kemeny, WR Jarnagin, M Capanu… - Journal of Clinical …, 2010 - ascopubs.org
3557 Background: To determine whether intravenous bevacizumab (Bev) added to adjuvant
systemic chemotherapy and hepatic arterial infusion (HAI) after liver resection increases …

Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases …

NE Kemeny, WR Jarnagin, M Capanu… - Journal of Clinical …, 2010 - europepmc.org
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with
or without bevacizumab in patients with resected hepatic metastases from colorectal cancer …

[引用][C] Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic …

NE KEMENY, WR JARNAGIN… - Journal of …, 2011 - American Society of Clinical …